n-(1-methyl-2-phenylethyl)adenosine has been researched along with 8-cyclopentyl-3-(3-((4-(fluorosulfonyl)benzoyl)oxy)propyl)-1-propylxanthine in 1 studies
| Studies (n-(1-methyl-2-phenylethyl)adenosine) | Trials (n-(1-methyl-2-phenylethyl)adenosine) | Recent Studies (post-2010) (n-(1-methyl-2-phenylethyl)adenosine) | Studies (8-cyclopentyl-3-(3-((4-(fluorosulfonyl)benzoyl)oxy)propyl)-1-propylxanthine) | Trials (8-cyclopentyl-3-(3-((4-(fluorosulfonyl)benzoyl)oxy)propyl)-1-propylxanthine) | Recent Studies (post-2010) (8-cyclopentyl-3-(3-((4-(fluorosulfonyl)benzoyl)oxy)propyl)-1-propylxanthine) |
|---|---|---|---|---|---|
| 134 | 0 | 4 | 28 | 0 | 12 |
| Protein | Taxonomy | n-(1-methyl-2-phenylethyl)adenosine (IC50) | 8-cyclopentyl-3-(3-((4-(fluorosulfonyl)benzoyl)oxy)propyl)-1-propylxanthine (IC50) |
|---|---|---|---|
| Adenosine receptor A2b | Rattus norvegicus (Norway rat) | 9 | |
| Adenosine receptor A1 | Homo sapiens (human) | 0.0112 | |
| Adenosine receptor A2a | Rattus norvegicus (Norway rat) | 4.5006 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belardinelli, L; Dennis, DM; Morey, TE | 1 |
1 other study(ies) available for n-(1-methyl-2-phenylethyl)adenosine and 8-cyclopentyl-3-(3-((4-(fluorosulfonyl)benzoyl)oxy)propyl)-1-propylxanthine
| Article | Year |
|---|---|
Validation of Furchgott's method to determine agonist-dependent A1-adenosine receptor reserve in guinea-pig atrium.
Topics: Adenosine; Animals; Blood Pressure; Dose-Response Relationship, Drug; Female; Guinea Pigs; Heart Atria; In Vitro Techniques; Male; Methods; Purinergic P1 Receptor Agonists; Radioligand Assay; Receptors, Purinergic P1; Xanthines | 1998 |